| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |